Memorial Sloan Kettering Cancer Center as of March 31, 2022
Portfolio Holdings for Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center holds 6 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Royalty Pharma Shs Cl A (RPRX) | 50.9 | $44M | 1.1M | 38.96 | |
| Vaneck Etf Trust Gold Miners Etf (GDX) | 32.8 | $28M | 739k | 38.35 | |
| Caribou Biosciences (CRBU) | 7.2 | $6.2M | 674k | 9.18 | |
| Oric Pharmaceuticals (ORIC) | 3.7 | $3.2M | 602k | 5.34 | |
| Illumina (ILMN) | 2.8 | $2.4M | 6.9k | 349.35 | |
| Y Mabs Therapeutics (YMAB) | 2.6 | $2.3M | 191k | 11.88 |
